Ask the Expert with Dr. Chris Mecoli
December 16 - December 20
Ask the Expert with Dr. Mecoli
Diagnosing and Treating Myositis, December 16-20th
Do you have questions you wish you could ask one of the experts in myositis? You do! Join us on the Myositis Support Community on December 16-20th to submit your questions to Dr. Mecoli.
Dr. Chris Mecoli with Johns Hopkins Myositis Center will be available to answer your questions related to diagnosing and treating myositis.
Mark your calendar and prepare your questions. If you’re not already a member, join the Myositis Support Community today to ensure you are able to ask Dr. Mecoli your questions!
How it works
You must be a registered member of the Myositis Support Community, our free, anonymous 24/7 educational and caring support community for myositis patients and caregivers.
- On December 16th, a post will be created titled, “Ask the Expert with Dr. Chris Mecoli” that will provide the details of how to submit your questions.
- Submit your questions between Decemember 16-20th.
- Dr. Mecoli will review and answer your questions.
- Our friends at Inspire will post the responses in the Ask the Expert topic discussion.
We ask that you please understand if he is unable to get to your question due to time or topic constraints.
Dr. Christopher Mecoli is an Assistant Professor of Medicine and Director of Research Operations and Physician Lead for the Myositis Precision Center of Excellence at Johns Hopkins. He is a physician-scientist in the Division of Rheumatology and a member of the renowned Johns Hopkins Myositis Center.
Dr. Mecoli is a graduate of New Jersey Medical School and received a Master’s degree in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He pursued internship and residency training at the University of Pennsylvania in Philadelphia, after which he completed a fellowship in rheumatology at Johns Hopkins.
Dr. Mecoli’s research focus includes the association between cancer and myositis, the development of myositis patient-reported outcome measures, and autoantibodies.